Drug
Sparc1210
Sparc1210: highest development phase Phase 1, developed by Sun Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Sun Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| SPARC1210 NCT02136927 | Phase 1 | Breast Cancer |
Latest
No recent events.
Follow Sparc1210 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.